Excipients for Direct Compaction
This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Special Issue Information
Dear Colleagues,
Tablets have long been, and still remain, the first-hand choice for administrating medicines. Regarding tablet manufacturing, direct compaction of powder formulations is preferred compared to granulation prior to compaction. However, direct compaction of powders sets high demands on the technical properties of the powder blend in order to ensure that the manufactured tablets meet the product requirements. As the predominant fraction of a tablet typically consists of excipients, the suitability of a powder formulation for direct compaction is mainly governed by the properties of the excipients. This Special Issue aims to highlight new approaches to direct compaction of powders using either traditional or novel excipients in addition to the excipient properties critical for the manufacturing performance of the powder.
We are pleased to invite you to contribute your research in this interesting field to the Special Issue on “Excipients for Direct Compaction”, and we welcome original research articles, communications, and reviews.
We look forward to receiving your contributions.
Dr. Ann-Sofie Persson
Dr. Josefina Nordström
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- powders
- excipients
- compaction
- compression
- tablets
- flowability
- mechanical properties
- tablet tensile strength
- compactibility
- tabletability
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
Pharmaceutics - ISSN 1999-4923